163 related articles for article (PubMed ID: 20857513)
1. Crush stenting with drug-eluting stents: relevance of coronary bifurcation lesion location on angiographic and clinical outcomes.
Chen SL; Zhang JJ; Ye F; Liu ZZ; Zhu ZS; Lin S; Tian NL; Fang WY; Chen YD; Sun XW; Wei M; Shan SJ; Kan J; Qian J; Yang S; Yuan ZB; Kwan TW; Hu DY
Clin Cardiol; 2010 Dec; 33(12):E32-9. PubMed ID: 20857513
[TBL] [Abstract][Full Text] [Related]
2. Comparative assessment of mammalian target of rapamycin inhibitor-eluting stents in the treatment of coronary artery bifurcation lesions: the CASTOR-Bifurcation registry.
Sgueglia GA; Burzotta F; Trani C; Todaro D; Talarico GP; Niccoli G; Porto I; Leone AM; Coluccia V; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Catheter Cardiovasc Interv; 2011 Mar; 77(4):503-9. PubMed ID: 20602477
[TBL] [Abstract][Full Text] [Related]
3. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of sirolimus-eluting stents vs. paclitaxel-eluting stents in unprotected left main coronary artery bifurcation lesions.
Song PS; Ryu DR; Song YB; Hahn JY; Choi JH; Choi SH; Lee SH; Hong KP; Park JE; Gwon HC
Clin Cardiol; 2011 Jun; 34(6):378-83. PubMed ID: 21538383
[TBL] [Abstract][Full Text] [Related]
5. Choice of stenting strategy in true coronary artery bifurcation lesions.
Lin QF; Luo YK; Lin CG; Peng YF; Zhen XC; Chen LL
Coron Artery Dis; 2010 Sep; 21(6):345-51. PubMed ID: 20613498
[TBL] [Abstract][Full Text] [Related]
6. Five-year clinical follow-up of unprotected left main bifurcation lesion stenting: one-stent versus two-stent techniques versus double-kissing crush technique.
Chen SL; Zhang Y; Xu B; Ye F; Zhang J; Tian N; Liu Z; Qian X; Ding S; Li F; Zhang A; Liu Y; Lin S
EuroIntervention; 2012 Nov; 8(7):803-14. PubMed ID: 23171801
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical results and predictors of adverse outcomes after drug-eluting stent implantation for bifurcation lesions in a real-world practice: the COBIS (Coronary Bifurcation Stenting) registry.
Gwon HC; Choi SH; Song YB; Hahn JY; Jeong MH; Seong IW; Kim HS; Rha SW; Yang JY; Yoon JH; Tahk SJ; Seung KB; Jang Y; Park SJ
Circ J; 2010 Nov; 74(11):2322-8. PubMed ID: 20890049
[TBL] [Abstract][Full Text] [Related]
8. Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: final results of the intracoronary stenting and angiographic restenosis - test equivalence between two drug-eluting stents (ISAR-TEST) trial.
King L; Byrne RA; Mehilli J; Schömig A; Kastrati A; Pache J
Catheter Cardiovasc Interv; 2013 Jan; 81(1):E23-8. PubMed ID: 22431239
[TBL] [Abstract][Full Text] [Related]
9. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
[TBL] [Abstract][Full Text] [Related]
10. Comparison of double kissing crush versus Culotte stenting for unprotected distal left main bifurcation lesions: results from a multicenter, randomized, prospective DKCRUSH-III study.
Chen SL; Xu B; Han YL; Sheiban I; Zhang JJ; Ye F; Kwan TW; Paiboon C; Zhou YJ; Lv SZ; Dangas GD; Xu YW; Wen SY; Hong L; Zhang RY; Wang HC; Jiang TM; Wang Y; Chen F; Yuan ZY; Li WM; Leon MB
J Am Coll Cardiol; 2013 Apr; 61(14):1482-8. PubMed ID: 23490040
[TBL] [Abstract][Full Text] [Related]
11. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial.
Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Kim HS; Park SJ
JACC Cardiovasc Interv; 2011 Mar; 4(3):310-6. PubMed ID: 21435609
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions: results from the DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) trial.
Chen SL; Santoso T; Zhang JJ; Ye F; Xu YW; Fu Q; Kan J; Paiboon C; Zhou Y; Ding SQ; Kwan TW
J Am Coll Cardiol; 2011 Feb; 57(8):914-20. PubMed ID: 21329837
[TBL] [Abstract][Full Text] [Related]
13. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE;
JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: the EUCATAX trial.
Rodriguez AE; Vigo CF; Delacasa A; Mieres J; Fernandez-Pereira C; Bernardi V; Bettinoti M; Rodriguez-Granillo AM; Rodriguez-Granillo G; Santaera O; Curotto V; Rubilar B; Tronge J; Palacios IF; Antoniucci D;
Catheter Cardiovasc Interv; 2011 Feb; 77(3):335-42. PubMed ID: 20824769
[TBL] [Abstract][Full Text] [Related]
15. Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients.
Birkmeier KA; Kastrati A; Byrne RA; Holle H; Schulz S; Tiroch K; Kufner S; Massberg S; Laugwitz KL; Schömig A; Mehilli J
Catheter Cardiovasc Interv; 2011 Mar; 77(4):494-501. PubMed ID: 20824758
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: the Nordic stent technique study.
Erglis A; Kumsars I; Niemelä M; Kervinen K; Maeng M; Lassen JF; Gunnes P; Stavnes S; Jensen JS; Galløe A; Narbute I; Sondore D; Mäkikallio T; Ylitalo K; Christiansen EH; Ravkilde J; Steigen TK; Mannsverk J; Thayssen P; Hansen KN; Syvänne M; Helqvist S; Kjell N; Wiseth R; Aarøe J; Puhakka M; Thuesen L;
Circ Cardiovasc Interv; 2009 Feb; 2(1):27-34. PubMed ID: 20031690
[TBL] [Abstract][Full Text] [Related]
17. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
Novack V; Cutlip D; Kleiman N; Pencina M; Mauri L; Yen CH; Berger P; Goldberg S; Kellett M; Waksman R; Hong M; Raizner AE; Cohen DJ
JACC Cardiovasc Interv; 2009 Aug; 2(8):767-75. PubMed ID: 19695546
[TBL] [Abstract][Full Text] [Related]
18. Randomized Comparison of FFR-Guided and Angiography-Guided Provisional Stenting of True Coronary Bifurcation Lesions: The DKCRUSH-VI Trial (Double Kissing Crush Versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions VI).
Chen SL; Ye F; Zhang JJ; Xu T; Tian NL; Liu ZZ; Lin S; Shan SJ; Ge Z; You W; Liu YQ; Qian XS; Li F; Yang S; Kwan TW; Xu B; Stone GW
JACC Cardiovasc Interv; 2015 Apr; 8(4):536-46. PubMed ID: 25819187
[TBL] [Abstract][Full Text] [Related]
19. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
Wiemer M; Serruys PW; Miquel-Hebert K; Neumann FJ; Piek JJ; Grube E; Haase J; Thuesen L; Hamm C
Catheter Cardiovasc Interv; 2010 Jun; 75(7):997-1003. PubMed ID: 20517959
[TBL] [Abstract][Full Text] [Related]
20. Angiographic restenosis and clinical recurrence after sirolimus- and paclitaxel-eluting stent implantation.
Vlaar PJ; Zijlstra F
JACC Cardiovasc Interv; 2009 Aug; 2(8):776-8. PubMed ID: 19695547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
